P3‐416: Aβ Stimulation Leads to Elevated Levels of Heparan Sulfate Proteoglycans in Glial Cells
Paul O' Callaghan,Elina Sandwall,Jin-Ping Li,Hong Yu,Rivka Ravid,Zhi-Zhong Guan,Toin H. van Kuppevelt,Lars N.G. Nilsson,Martin Ingelsson,Bradley T. Hyman,Hannu Kalimo,Ulf Lindahl,Lars Lannfelt,Xiao Zhang
DOI: https://doi.org/10.1016/j.jalz.2008.05.1987
2008-01-01
Abstract:The presence of heparan sulfate (HS) and HS proteoglycans (HSPGs) in the β-amyloid (Aβ) plaques of Alzheimer's disease (AD) is well documented. There is in vitro evidence that HS is capable of accelerating and stabilising Aβ aggregation and it has been suggested that this interaction is important for initial plaque deposition. Furthermore, Aβ is capable of binding HS with high affinity and this relationship is possibly mutually protective. As part of the immune/inflammatory response, neuritic plaques are surrounded by activated astrocytes and microglia, many of which perish at the plaque site forming the glial scar. Results from animal models of brain injury have demonstrated glial upregualtion of the membrane bound HSPGs, glypican (GPC) and syndecan (SDC), which have been implicated in regulation of axon regeneration. Here we discuss the possibility that HS accumulation, with specific plaque types and Aβ species, is derived from Aβ-stimulated glial cells presenting with elevated levels of membrane bound GPC1 and SDC3. Brain sections from sporadic AD, Swedish mutation AD, Presenilin-1 (PS1)–Δ9 AD and Tg2576 mice were immunostained for Aβ, HS, HSPGs, and glial markers. Astrocytes and microglia from neonatal C57BL mice were separated; stimulated with aggregated Aβ42; and GPC1 and SDC3 levels for each cell type was analysed by Western immunoblotting. GPC1 and SDC3 immunostaining overlaps with astrocytes around the neuritic, Aβ40/HS-positive plaques of sporadic AD and Swedish mutation AD. Conversely, GPC1, SDC3 and HS are largely absent from the diffuse Aβ42 rich plaques found in Swedish mutation AD and PS1–Δ9 AD, which incite little to no astrocyte response. Immunostaining in Tg2576 mice showed that glial cells in contact with Aβ/HS-positive deposits, expressed GPC1 and SDC3. Purified astrocytes and microglia, stimulated with aggregated Aβ42, presented with elevated levels of GPC1 and SDC3. Here we describe the preferential accumulation of HS with Aβ40-positive plaques and its relative absence from Aβ42-rich diffuse deposits in AD. This discrimination coincided with the presence or absence of astrocytes, which overlapped with the HSPGs, GPC1 and SDC3. Finally, cultures of purified astrocytes and microglia revealed elevated levels of both HSPGs, in response to Aβ stimulation.